Table 2.
Characteristics related to use of AAS of the non-dependent (AAS) and dependent (AASdep) subgroups
| AAS (n = 43) |
AASdep (n = 51) |
Statistics | ||
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | t | p value | |
| Debut age of AAS use | 23.3 (5.8) | 21.6 (7.0) | 1.25 | 0.214 |
| Total years of AAS use | 6.5 (5.4) | 10.0 (6.1) | 2.9 | 0.043 |
| Estimated weekly AAS dose | 1059.5 (1275.6)1 | 1287.2 (864.4) 2 | 0.99 | 0.322 |
| n (%) | n (%) | X2 | p value | |
| Current AAS use | 27 (62.8) | 32 (62.8%) | 0.00 | 0.996 |
| Physical side effects | 33 (76.8%) | 48 (94.1%) | 5.91 | 0.015 |
| Psychological side effects | 26 (60.5%) | 46 (90.2%) | 11.50 | 0.001 |
| Cognitive side effects | 11 (25.6%) | 31 (60.8%) | 11.70 | 0.001 |
1n = 38 due to missing data
2n = 50 due to missing data